[Federal Register Volume 66, Number 196 (Wednesday, October 10, 2001)]
[Notices]
[Page 51675]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-25370]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Science Board to the Food and Drug Administration Advisory 
Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Science Board to the Food and Drug 
Administration.
    General Function of the Committee: The board shall provide advice 
primarily to the agency's Senior Advisor for Science, and as needed, to 
the Commissioner of Food and Drugs and other appropriate officials on 
specific complex and technical issues as well as emerging issues within 
the scientific community in industry and academia. Additionally, the 
board will provide advice to the agency on keeping pace with technical 
and scientific evolutions in the fields of regulatory science, 
formulating an appropriate research agenda, and upgrading its 
scientific and research facilities to keep pace with these changes. It 
will also provide the means for critical review of agency sponsored 
intramural and extramural scientific research programs.
    Date and Time: The meeting will be held on November 16, 2001, from 
9 a.m. to 4:30 p.m.
    Location: 5630 Fishers Lane, rm. 1066, Rockville, MD.
    Contact: Susan Mackie Bond, Office of Science Coordination and 
Communication (HF-33), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-6687, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 12603. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: The board will hear and discuss external science review for 
FDA's Center for Devices and Radiological Health, emerging issues in 
FDA's oversight of clinical research, and emerging issues in 
pharmaceutical manufacturing.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by November 1, 
2001. Oral presentations from the public will be scheduled between 
approximately 1 p.m. and 2 p.m. Time allotted for each presentation may 
be limited. Those desiring to make formal oral presentations should 
notify the contact person before November 1, 2001, and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: October 1, 2001.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 01-25370 Filed 10-9-01; 8:45 am]
BILLING CODE 4160-01-S